Mental health follow-up and treatment engagement following suicide risk screening in the Veterans Health Administration.

Autor: Bahraini N; VA Rocky Mountain Mental Illness Research, Education and Clinical Center (MIRECC), Rocky Mountain Regional VA Medical Center, Aurora, CO, United States of America.; Department of Psychiatry University of Colorado, Anschutz School of Medicine, Aurora, CO, United States of America.; Department of Physical Medicine and Rehabilitation, University of Colorado, Anschutz School of Medicine, Aurora, CO, United States of America., Reis DJ; VA Rocky Mountain Mental Illness Research, Education and Clinical Center (MIRECC), Rocky Mountain Regional VA Medical Center, Aurora, CO, United States of America.; Department of Psychiatry University of Colorado, Anschutz School of Medicine, Aurora, CO, United States of America., Matarazzo BB; VA Rocky Mountain Mental Illness Research, Education and Clinical Center (MIRECC), Rocky Mountain Regional VA Medical Center, Aurora, CO, United States of America.; Department of Psychiatry University of Colorado, Anschutz School of Medicine, Aurora, CO, United States of America., Hostetter T; VA Rocky Mountain Mental Illness Research, Education and Clinical Center (MIRECC), Rocky Mountain Regional VA Medical Center, Aurora, CO, United States of America., Wade C; VA Rocky Mountain Mental Illness Research, Education and Clinical Center (MIRECC), Rocky Mountain Regional VA Medical Center, Aurora, CO, United States of America., Brenner LA; VA Rocky Mountain Mental Illness Research, Education and Clinical Center (MIRECC), Rocky Mountain Regional VA Medical Center, Aurora, CO, United States of America.; Department of Psychiatry University of Colorado, Anschutz School of Medicine, Aurora, CO, United States of America.; Department of Physical Medicine and Rehabilitation, University of Colorado, Anschutz School of Medicine, Aurora, CO, United States of America.; Department of Neurology, University of Colorado, Anschutz School of Medicine, Aurora, CO, United States of America.
Jazyk: angličtina
Zdroj: PloS one [PLoS One] 2022 Mar 17; Vol. 17 (3), pp. e0265474. Date of Electronic Publication: 2022 Mar 17 (Print Publication: 2022).
DOI: 10.1371/journal.pone.0265474
Abstrakt: Importance: Understanding the extent to which population-level suicide risk screening facilities follow-up and engagement in mental health treatment is important as engaging at-risk individuals in treatment is critical to reducing suicidal behaviors.
Objective: To evaluate mental health follow-up and treatment engagement in the Veterans Health Administration (VHA) following administration of the Columbia-Suicide Severity Rating Scale (C-SSRS) screen, a component of the VHA's universal suicide risk screening program.
Design: This cross-sectional study used data from VA's Corporate Data Warehouse.
Settings: 140 VHA Medical Centers.
Participants: Patients who completed the C-SSRS screen in ambulatory care between October 1, 2018-September 30, 2020.
Exposure: Standardized suicide risk screening.
Main Outcomes and Measures: Mental health follow-up (one or more visits within 30 days of C-SSRS screening) and treatment engagement (two or more visits within 90 days of C-SSRS screening) were examined.
Results: 97,224 Veterans in Fiscal Year 2019 (FY19) (mean age 51.4 years; 86.8% male; 64.8% white, 22.4% African-American) and 58,693 Veterans in FY20 (mean age 49.6 years; 85.5% male; 63.4% white, 21.9% African-American) received the C-SSRS screen. Across FYs, a positive C-SSRS screen was associated with increased probability of mental health follow-up and treatment engagement. Patients who were not seen in mental health in the year prior to screening had the greatest increase in probability of mental health follow-up and engagement following a positive screen (P<0.001). For FY19, a positive C-SSRS screen in non-mental health connected patients was associated with an increased probability of follow-up from 49.8% to 79.5% (relative risk = 1.60) and engagement from 39.5% to 63.6% (relative risk = 1.61). For mental health-connected patients, a positive C-SSRS screen was associated with a smaller increase in probability of follow-up from 75.8% to 87.6% (relative risk = 1.16) and engagement from 63.3% to 76.4% (relative risk = 1.21). Results for FY20 were similar.
Conclusions and Relevance: Identification of suicide risk through population-level screening was associated with increased mental health follow-up and engagement, particularly for non-mental health connected patients. Findings support the use of a standardized, comprehensive suicide risk screening program for managing elevated suicide risk in a large healthcare system.
Competing Interests: The authors have declared that no competing interests exist.
Databáze: MEDLINE
Externí odkaz:
Nepřihlášeným uživatelům se plný text nezobrazuje